Education
About Us
Working with TipRanks
Follow Us
Quipt Home Medical Corp (QIPT)
:QIPT
Earnings Data
Report Date
Aug 18, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.03Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: -33.80%
|Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with stable adjusted EBITDA margins and strong cash flow, but significant challenges included a revenue decline and customer base contraction. The sleep business showed resilience with no impact from GLP-1 medications, but the overall performance was hindered by external factors affecting patient volume and revenue.Company Guidance
During the Second Quarter 2025 earnings call for Quipt Home Medical Corp, the company provided guidance that focused on strategic priorities and financial performance metrics. The company reported a revenue of $57.4 million for fiscal Q2 2025, a 6% year-over-year decrease, primarily due to patient attrition following a capitated agreement and a non-renewed disposable supply contract. Adjusted EBITDA margin was reported at 23.3%, reflecting the company's efforts to enhance operational efficiency. Despite a net loss of $3 million or $0.07 per diluted share, Quipt maintained strong cash flow from operations at $18.3 million for the six months ending March 31, 2025. The company emphasized its commitment to organic growth, optimizing capital allocation, and expanding healthcare system partnerships. With a solid balance sheet, including $17.1 million in cash and total liquidity of $30.7 million, Quipt aims to enhance shareholder value through strategic initiatives and operational excellence.Stable Adjusted EBITDA Margin
Despite revenue softness, Quipt Home Medical achieved an adjusted EBITDA margin of 23.3%, a result of structural efficiencies initiatives that began in late 2024.
Strong Cash Flow from Operations
The company reported cash flow from operations of $18.3 million for the six months ended March 31, 2025, compared to $14.9 million for the same period in 2024.
High Recurring Revenue
Recurring revenue for Q2 2025 remains strong at 81% of total revenue.
Positive Developments in Sleep Business
GLP-1 medications showed no impact on demand, with steady referral activity for new device setups. Real-world data indicates a positive effect on treatment adherence.
---
QIPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
QIPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $2.13 | $1.67 | -21.60% |
Feb 10, 2025 | $3.02 | $2.95 | -2.32% |
Dec 16, 2024 | $3.07 | $2.60 | -15.15% |
Aug 14, 2024 | $3.34 | $2.74 | -17.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Quipt Home Medical Corp (QIPT) report earnings?
Quipt Home Medical Corp (QIPT) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
What is Quipt Home Medical Corp (QIPT) earnings time?
Quipt Home Medical Corp (QIPT) earnings time is at Aug 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is QIPT EPS forecast?
QIPT EPS forecast for the fiscal quarter 2025 (Q3) is -0.04.
---